검색어 : 통합검색[Mendelsohn Ben]
-
11
-
Review of Eli Ben-Joseph, Aesthetic Persuasion: Henry James, the Jews, and Race
-
Mendelsohn, J.;
;
(The Henry James review,
v.18,
1997,
pp.200-203)
-
12
-
Involvement of Tumor Necrosis Factor Alpha in Hippocampal Development and Function
-
Golan, H.;
Levav, T.;
Mendelsohn, A.;
Huleihel, M.;
Department of Developmental Molecular Genetics, Faculty of Health Sciences, Ben Gurion University, Beer-Sheva, Israel;
Department of Developmental Molecular Genetics, Faculty of Health Sciences, Ben Gurion University, Beer-Sheva, Israel;
Department of Developmental Molecular Genetics, Faculty of Health Sciences, Ben Gurion University, Beer-Sheva, Israel;
Department of Microbiology and Immunology, Faculty of Health Sciences, Ben Gurion University, Beer-Sheva, Israel;
(Cerebral cortex,
v.14,
2004,
pp.97-105)
-
13
-
Classification of early tuberculosis states to guide research for improved care and prevention: an international Delphi consensus exercise
-
Coussens, Anna K;
Zaidi, Syed M A;
Allwood, Brian W;
Dewan, Puneet K;
Gray, Glenda;
Kohli, Mikashmi;
Kredo, Tamara;
Marais, Ben J;
Marks, Guy B;
Martinez, Leo;
Ruhwald, Morten;
Scriba, Thomas J;
Seddon, James A;
Tisile, Phumeza;
Warner, Digby F;
Wilkinson, Robert J;
Esmail, Hanif;
Houben, Rein M G J;
Alland, David;
Behr, Marcel A;
Beko, Busisiwe B;
Burhan, Erlina;
Churchyard, Gavin;
Cobelens, Frank;
Denholm, Justin T;
Dinkele, Ryan;
Ellner, Jerrold J;
Fatima, Razia;
Haigh, Kate A;
Hatherill, Mark;
Horton, Katherine C;
Kendall, Emily A;
Khan, Palwasha Y;
MacPherson, Peter;
Malherbe, Stephanus T;
Mave, Vidya;
Mendelsohn, Simon C;
Musvosvi, Munyaradzi;
Nemes, Elisa;
Penn-Nicholson, Adam;
Ramamurthy, Dharanidharan;
Rangaka, Molebogeng X;
Sahu, Suvanand;
Schwalb, Alvaro;
Shah, Divya K;
Sheerin, Dylan;
Simon, Donald;
Steyn, Adrie J C;
Thu Anh, Nguyen;
Walzl, Gerhard;
Weller, Charlotte L;
Williams, Caroline ML;
Wong, Emily B;
Wood, Robin;
;
;
(The Lancet. Respiratory medicine,
v.12,
2024,
pp.484-498)
-
14
-
Genotype-Phenotype Correlation in NF1: Evidence for a More Severe Phenotype Associated with Missense Mutations Affecting <i>NF1</i> Codons 844–848
-
Koczkowska, Magdalena;
Chen, Yunjia;
Callens, Tom;
Gomes, Alicia;
Sharp, Angela;
Johnson, Sherrell;
Hsiao, Meng-Chang;
Chen, Zhenbin;
Balasubramanian, Meena;
Barnett, Christopher P.;
Becker, Troy A.;
Ben-Shachar, Shay;
Bertola, Debora R.;
Blakeley, Jaishri O.;
Burkitt-Wright, Emma M.M.;
Callaway, Alison;
Crenshaw, Melissa;
Cunha, Karin S.;
Cunningham, Mitch;
D’Agostino, Maria D.;
Dahan, Karin;
De Luca, Alessandro;
Destré
e, Anne;
Dhamija, Radhika;
Eoli, Marica;
Evans, D. Gareth R.;
Galvin-Parton, Patricia;
George-Abraham, Jaya K.;
Gripp, Karen W.;
Guevara-Campos, Jose;
Hanchard, Neil A.;
Herná
ndez-Chico, Concepcion;
Immken, LaDonna;
Janssens, Sandra;
Jones, Kristi J.;
Keena, Beth A.;
Kochhar, Aaina;
Liebelt, Jan;
Martir-Negron, Arelis;
Mahoney, Maurice J.;
Maystadt, Isabelle;
McDougall, Carey;
McEntagart, Meriel;
Mendelsohn, Nancy;
Miller, David T.;
Mortier, Geert;
Morton, Jenny;
Pappas, John;
Plotkin, Scott R.;
Pond, Dine;
Department of Genetics, University of Alabama at Birmingham, Birmingham, AL 35294, USA;
Department of Genetics, University of Alabama at Birmingham, Birmingham, AL 35294, USA;
Department of Genetics, University of Alabama at Birmingham, Birmingham, AL 35294, USA;
Department of Genetics, University of Alabama at Birmingham, Birmingham, AL 35294, USA;
Department of Genetics, University of Alabama at Birmingham, Birmingham, AL 35294, USA;
Department of Genetics, University of Alabama at Birmingham, Birmingham, AL 35294, USA;
Department of Genetics, University of Alabama at Birmingham, Birmingham, AL 35294, USA;
Department of Genetics, University of Alabama at Birmingham, Birmingham, AL 35294, USA;
Sheffield Clinical Genetics Service, Sheffield Children’s NHS Foundation Trust, Sheffield S10 2TH, UK;
Women’s and Children’s Hospital/SA Pathology, North Adelaide, SA 5006, Australia;
Medical Genetics, John Hopkins All Children’s Hospital, St. Petersburg, FL 33701, USA;
The G;
(American journal of human genetics,
v.102,
2018,
pp.69-87)
-
15
-
The Warsaw Jewish Community between the Two World Wars. National Autonomy Enchained by Law and Reality, 1917-1939 [‮קהילת וורשא בין שתי מלחמות העולם: אוטונומיה לאומית בכבלי החוק‬ 1939-1917 ‮והמציאות‬]
-
Mendelsohn, Ezra;
Guterman, Alexander;
;
(The Jewish quarterly review,
v.89,
1999,
pp.450)
-
16
-
Persistent neonatal thrombocytopenia can be caused by IgA antiplatelet antibodies in breast milk of immune thrombocytopenic mothers
-
Hauschner, Hagit;
Rosenberg, Nurit;
Seligsohn, Uri;
Mendelsohn, Rafael;
Simmonds, Aryeh;
Shiff, Yakov;
Schachter, Yaakov;
Aviner, Shraga;
Sharon, Nechama;
Amalia Biron Research Institute of Thrombosis and Hemostasis, Chaim Sheba Medical Center, Tel Hashomer and Sackler Faculty of Medicine, Tel-Aviv University, Tel-Aviv, Israel;
;
Amalia Biron Research Institute of Thrombosis and Hemostasis, Chaim Sheba Medical Center, Tel Hashomer and Sackler Faculty of Medicine, Tel-Aviv University, Tel-Aviv, Israel;
;
Amalia Biron Research Institute of Thrombosis and Hemostasis, Chaim Sheba Medical Center, Tel Hashomer and Sackler Faculty of Medicine, Tel-Aviv University, Tel-Aviv, Israel;
;
Pediatric Department, Tel Aviv Sourasky Medical Center, Tel Aviv, Israel;
;
Ruth and Bruce Rappoport Faculty of Medicine, Technion, Haifa, Israel;
;
Ruth and Bruce Rappoport Faculty of Medicine, Technion, Haifa, Israel;
;
Pediatric Department, Tel Aviv Sourasky Medical Center, Tel Aviv, Israel;
;
Department of Pediatrics, Barzilai University Medical Center, Ashkelon, and Faculty of Health Sciences, Ben-Gurion University of the Negev, Beer Sheva, Israel;
and;
Ruth;
(Blood,
v.126,
2015,
pp.661-664)
-
17
-
Challenges in initiating and conducting personalized cancer therapy trials: perspectives from WINTHER, a Worldwide Innovative Network (WIN) Consortium trial
-
Rodon, J.;
Soria, J. C.;
Berger, R.;
Batist, G.;
Tsimberidou, A.;
Bresson, C.;
Lee, J. J.;
Rubin, E.;
Onn, A.;
Schilsky, R. L.;
Miller, W. H.;
Eggermont, A. M.;
Mendelsohn, J.;
Lazar, V.;
Kurzrock, R.;
Vall D'Hebron Institute of Oncology and Universitat Autonoma de Barcelona, Barcelona, Spain;
Gustave Roussy Cancer Campus Grand Paris, Villejuif, France;
Oncology Institute, Chaim Sheba Medical Center, Tel-Hashomer, Israel;
Segal Cancer Center, Jewish General Hospital Mcgill University, Montreal;
The University of Texas MD Anderson Cancer Center, Houston, USA;
WIN Consortium, Villejuif, France;
The University of Texas MD Anderson Cancer Center, Houston, USA;
The National Institute of Biotechnology in the Negev, Ben Gurion University, Beer-Sheva, Israel;
Oncology Institute, Chaim Sheba Medical Center, Tel-Hashomer, Israel;
American Society of Clinical Oncology (ASCO), Alexandria;
Segal Cancer Center, Jewish General Hospital Mcgill University, Montreal;
Gustave Roussy Cancer Campus Grand Paris, Villejuif, France;
The University of Texas MD Anderson Cancer Center, Houston, USA;
Gustave Roussy Cancer Campus Grand Paris, Villejuif, France;
Center for Personalized Cancer Therap;
(Annals of oncology : official journal of the European Society for Medical Oncology,
v.26,
2015,
pp.1791-1798)
-
18
-
WINTHER: An international WIN Consortium precision medicine trial using genomic and transcriptomic analysis in patients with advanced malignancies.
-
Rodon, Jordi;
Soria, Jean-Charles;
Berger, Raanan;
Miller, Wilson H.;
Lazar, Vladimir;
Rubin, Eitan;
Tsimberidou, Apostolia Maria;
Saintigny, Pierre;
Ackerstein, Aliza;
Brana, Irene;
Loriot, Yohann;
Afshar, Mohammad;
Miller, Vincent A.;
Wunder, Fanny;
Bresson, Catherine;
Martini, Jean-Francois;
Mendelsohn, John;
Schilsky, Richard L.;
Lee, J. Jack;
Kurzrock, Razelle;
Vall d'Hebron Institute of Oncology, Barcelona, Spain;
;
Gustave Roussy, Villejuif, France;
;
Institute of Oncology, Sheba Medical Center, Ramat Gan, Israel;
;
Segal Cancer Centre at the Jewish General Hospital, McGill University, Montreal, QC, Canada;
;
Worldwide Innovative Network (WIN) Association - WIN Consortium, Villejuif, France;
;
Ben-Gurion University of the Negev, Beer Sheva, Israel;
;
The University of Texas MD Anderson Cancer Center, Houston, TX;
;
Centre Lé
on Bé
rard, Lyon, France;
;
Chaim Sheba Medical Center, Ramat Gan, Israel;
;
Vall d'Hebron Institute of Oncology, Barcelona, Spain;
;
Gustave Roussy, Villejuif, France;
;
Ariana Pharma, Paris, France;
;
Foundation Medicine, Inc., Cambridge, MA;
;
Worldwide Innovative Network (WIN) Association - WIN Consortium, Villejuif, France;
;
Worldwide Innovative Network (WIN) Association - WIN Consortium, Villejuif, France;
;
Pfizer Oncology, La Jolla, CA;
;
University of Texas MD Anderson Cancer Center and Worldwide I;
(Journal of clinical oncology : official journal of the American Society of Clinical Oncology,
v.36,
2018,
pp.12011-12011)
-
19
-
A simplified interventional mapping system (SIMS) for the selection of combinations of targeted treatments in non-small cell lung cancer
-
Lazar, Vladimir;
Rubin, Eitan;
Depil, Stephane;
Pawitan, Yudi;
Martini, Jean-Franç
ois;
Gomez-Navarro, Jesus;
Yver, Antoine;
Kan, Zhengyin;
Dry, Jonathan R.;
Kehren, Jeanne;
Validire, Pierre;
Rodon, Jordi;
Vielh, Philippe;
Ducreux, Michel;
Galbraith, Susan;
Lehnert, Manfred;
Onn, Amir;
Berger, Raanan;
Pierotti, Marco A.;
Porgador, Angel;
Pramesh, CS;
Ye, Ding-wei;
Carvalho, Andre L.;
Batist, Gerald;
Le Chevalier, Thierry;
Morice, Philippe;
Besse, Benjamin;
Vassal, Gilles;
Mortlock, Andrew;
Hansson, Johan;
Berindan-Neagoe, Ioana;
Dann, Robert;
Haspel, Joel;
Irimie, Alexandru;
Laderman, Steve;
Nechushtan, Hovav;
Al Omari, Amal S.;
Haywood, Trent;
Bresson, Catherine;
Soo, Khee Chee;
Osman, Iman;
Mata, Hilario;
Lee, Jack J.;
Jhaveri, Komal;
Meurice, Guillaume;
Palmer, Gary;
Lacroix, Ludovic;
Koscielny, Serge;
Eterovic, Karina Agda;
Blay, Jean-Yves;
Buller, Richard;
Eggermont, Alexander;
Schilsky, Richard L.;
Mendelsohn, John;
Sori;
Gustave-Roussy Cancer Center, Villejuif, France;
Ben-Gurion University of the Negev, Beer-Sheva, Israel;
Leon Berard Cancer Center, Lyon, France;
Karolinska Institutet, Stockholm, Sweden;
Pfizer Oncology Research, San Diego, CA;
Takeda Pharmaceuticals International Co., Cambridge, MA, USA;
AstraZeneca Pharmaceuticals LP, Global Medicines Development, Gaithersburg MD, USA;
Pfizer Oncology Research, San Diego, CA;
AstraZeneca Pharmaceuticals LP, Global Medicines Development, Gaithersburg MD, USA;
Sanofi, Paris, France;
Institut Mutualiste Montsouris, Paris, France;
Vall d'Hebron Institute of Oncology Universitat Autonoma de Barcelona, Barcelona, Spain;
Gustave-Roussy Cancer Center, Villejuif, France;
Gustave-Roussy Cancer Center, Villejuif, France;
AstraZeneca Pharmaceuticals LP, Global Medicines Development, Gaithersburg MD, USA;
Takeda Pharmaceuticals International Co., Cambridge, MA, USA;
Chaim Sheba Medical Center, Tel-Hashomer, Israel;
Chaim Sheba Medical Center, Te;
(Oncotarget,
v.6,
2015,
pp.14139-14152)